It is well known that increased oxidative stress in cardiovascular disease enhances RyR2 activity through reversible posttranslational modifications such as oxidative modifications and CaMKII (Ca /calmodulindependent protein kinase II)-dependent phosphorylation [44–48]. Here, RYR2 is linked to cardiovascular disorder.